Insider Trading activities of Diamedica Therapeutics Inc. (DMAC)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Diamedica Therapeutics Inc. (DMAC) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Diamedica Therapeutics Inc. since year 2005. Table 2 shows the detailed insider transactions of Diamedica Therapeutics Inc. since 2005. The reporting company's ticker symbol is DMAC. The reporting company's CIK number is 1401040.
The total value of stock buying since 2005 is $212,679.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Diamedica Therapeutics Inc. (DMAC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-08 8,260 $22,039 0 $0 0 $0
2019-05 23,000 $64,972 0 $0 0 $0
2019-03 150 $668 0 $0 0 $0
2018-12 31,250 $125,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Diamedica Therapeutics Inc. insiders (DMAC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-08-16 Pauls Dietrich John (President and CEO) Buy 1,000 2.68 2,677
2019-08-16 Alcorn Harry W Jr (Chief Medical Officer) Buy 7,260 2.67 19,362
2019-05-31 Pilnik Richard D. (Director) Buy 19,000 2.80 53,200
2019-05-24 Kellen Scott (CFO and Secretary) Buy 4,000 2.94 11,772
2019-03-27 Alcorn Harry W Jr (Chief Medical Officer) Buy 150 4.46 668
2018-12-11 Xiao Zhenyu (Director) Buy 3,250 4.00 13,000
2018-12-11 Pauls Dietrich John (President and CEO) Buy 5,000 4.00 20,000
2018-12-11 Pilnik Richard D. (Director) Buy 6,250 4.00 25,000
2018-12-11 Verdoorn Todd A. (Chief Scientific Officer) Buy 1,000 4.00 4,000
2018-12-11 Parsons James T. (Director) Buy 2,250 4.00 9,000
2018-12-11 Giuffre Randall Michael (Director) Buy 11,250 4.00 45,000
2018-12-11 Kellen Scott (CFO and Secretary) Buy 1,250 4.00 5,000
2018-12-11 Alcorn Harry W Jr (Chief Medical Officer) Buy 1,000 4.00 4,000

Insider trading activities including stock purchases, stock sales, and option exercises of DMAC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Diamedica Therapeutics Inc. (symbol DMAC, CIK number 1401040) see the Securities and Exchange Commission (SEC) website.